QUIDELORTHO CORP
QuidelOrtho (ticker QDEL) is a diagnostics company that develops, manufactures and sells rapid point‑of‑care tests, laboratory immunoassays and related instruments. With a market capitalisation near $2.03bn, the business generates revenue from one‑off instrument placements and recurring test kit and reagent sales across infectious disease, cardiometabolic and women’s health markets. Investors should note the company’s exposure to public‑health cycles — demand can spike in pandemics and recede afterwards — as well as regulatory approvals, reimbursement dynamics and competition from other diagnostics firms. Recent integration of acquisitions and manufacturing scale‑up are potential growth levers but introduce execution risk. Financial metrics such as margins, cash flow and debt levels are important to monitor. This is general educational information, not personalised investment advice; values can fall as well as rise and prospective investors should assess their objectives and seek professional guidance.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding QuidelOrtho's stock, anticipating a potential rise to $36.86.
Financial Health
QuidelOrtho Corp is performing well with strong profits and revenue, indicating healthy business operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring QDEL
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketDiagnostic Takeover Targets
This carefully selected group of stocks features innovative diagnostic companies that could become acquisition targets following recent takeover interest in the sector. Professional analysts have identified these companies for their unique technologies and established market positions in a consolidating healthcare landscape.
Published: July 15, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Diagnostics revenue drivers
Recurring reagent sales and instrument placements underpin revenue, though demand can be cyclical and influenced by public‑health events.
Global market exposure
Products serve hospitals and labs worldwide; regulatory approvals and reimbursement affect adoption and geographic expansion carries execution risk.
Product pipeline focus
New assays and automation could bolster growth and margins, but launch success and regulatory review remain uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
